Conduit Holdings Limited

LSE:CRE Stock Report

Market Cap: UK£752.7m

Conduit Holdings Valuation

Is CRE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CRE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CRE's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CRE's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CRE?

Key metric: As CRE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CRE. This is calculated by dividing CRE's market cap by their current earnings.
What is CRE's PE Ratio?
PE Ratio4.6x
EarningsUS$210.30m
Market CapUS$951.03m

Price to Earnings Ratio vs Peers

How does CRE's PE Ratio compare to its peers?

The above table shows the PE ratio for CRE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average27.1x
JUST Just Group
16.2x8.2%UK£1.4b
LRE Lancashire Holdings
5.1x-7.2%UK£1.5b
CSN Chesnara
76.1x11.8%UK£385.0m
SBRE Sabre Insurance Group
11.1x13.7%UK£327.4m
CRE Conduit Holdings
4.6x10.8%UK£752.7m

Price-To-Earnings vs Peers: CRE is good value based on its Price-To-Earnings Ratio (4.6x) compared to the peer average (27.1x).

Price to Earnings Ratio vs Industry

How does CRE's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
CRE 4.6xIndustry Avg. 11.8xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CRE is good value based on its Price-To-Earnings Ratio (4.6x) compared to the European Insurance industry average (11.8x).

Price to Earnings Ratio vs Fair Ratio

What is CRE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CRE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio4.6x
Fair PE Ratio13.4x

Price-To-Earnings vs Fair Ratio: CRE is good value based on its Price-To-Earnings Ratio (4.6x) compared to the estimated Fair Price-To-Earnings Ratio (13.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CRE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£4.90
UK£6.51
+32.9%
6.9%UK£7.17UK£5.77n/a5
Nov ’25UK£5.27
UK£6.76
+28.2%
4.6%UK£7.08UK£6.19n/a5
Oct ’25UK£5.13
UK£6.67
+30.0%
4.4%UK£7.04UK£6.16n/a5
Sep ’25UK£5.23
UK£6.78
+29.7%
4.5%UK£7.19UK£6.29n/a5
Aug ’25UK£5.20
UK£6.78
+30.4%
4.5%UK£7.19UK£6.29n/a5
Jul ’25UK£4.97
UK£6.79
+36.8%
4.2%UK£7.12UK£6.30n/a5
Jun ’25UK£5.30
UK£6.63
+25.1%
6.3%UK£7.10UK£6.00n/a5
May ’25UK£5.04
UK£6.60
+31.0%
6.3%UK£7.16UK£6.04n/a5
Apr ’25UK£5.18
UK£6.57
+26.9%
6.2%UK£7.12UK£6.00n/a5
Mar ’25UK£5.16
UK£6.56
+27.1%
6.3%UK£7.10UK£5.98n/a5
Feb ’25UK£4.67
UK£6.25
+33.8%
6.4%UK£6.95UK£5.76n/a5
Jan ’25UK£4.69
UK£6.18
+31.7%
7.7%UK£6.99UK£5.53n/a5
Dec ’24UK£4.69
UK£6.18
+31.8%
7.7%UK£6.99UK£5.53n/a5
Nov ’24UK£4.40
UK£6.08
+38.3%
5.3%UK£6.42UK£5.49UK£5.275
Oct ’24UK£4.61
UK£6.06
+31.6%
3.4%UK£6.34UK£5.74UK£5.135
Sep ’24UK£4.66
UK£5.97
+28.3%
4.2%UK£6.27UK£5.61UK£5.235
Aug ’24UK£4.79
UK£6.09
+27.3%
5.4%UK£6.58UK£5.56UK£5.205
Jul ’24UK£4.61
UK£5.84
+26.8%
6.4%UK£6.38UK£5.22UK£4.975
Jun ’24UK£4.90
UK£5.70
+16.4%
13.1%UK£6.54UK£4.23UK£5.306
May ’24UK£4.85
UK£5.59
+15.3%
11.8%UK£6.33UK£4.25UK£5.046
Apr ’24UK£4.90
UK£5.59
+14.0%
11.8%UK£6.33UK£4.25UK£5.186
Mar ’24UK£4.98
UK£5.60
+12.4%
12.0%UK£6.48UK£4.35UK£5.166
Feb ’24UK£4.59
UK£5.41
+18.0%
11.4%UK£6.17UK£4.23UK£4.676
Jan ’24UK£4.28
UK£4.80
+12.2%
16.8%UK£5.76UK£3.75UK£4.696
Dec ’23UK£3.91
UK£4.80
+22.8%
16.8%UK£5.76UK£3.75UK£4.696
Nov ’23UK£3.37
UK£4.73
+40.4%
17.6%UK£5.78UK£3.79UK£4.406

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Talanx

€20.3b

Provides insurance and reinsurance products and services worldwide.

0QA8

€78.80

7D

6.2%

1Y

20.8%

Münchener Rückversicherungs-Gesellschaft in München

€62.6b

Engages in the insurance and reinsurance businesses worldwide.

0KFE

€472.30

7D

-1.5%

1Y

24.0%

Powszechny Zaklad Ubezpieczen

zł35.5b

Provides life and non-life insurance products and services in Poland, the Baltic States, and Ukraine.

0MYY

zł41.01

7D

-0.3%

1Y

n/a